Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient (original) (raw)

Prognostic value of quantitative immune alterations in melanoma patients

A. Tres

Oncología (Barcelona), 2006

View PDFchevron_right

Melanoma and immunotherapy bridge 2015

Angel Rivera

Journal of Translational Medicine, 2016

View PDFchevron_right

Immunologic escape and angiogenesis in human malignant melanoma

Pedro Redondo

Journal of the American Academy of Dermatology, 2003

View PDFchevron_right

Supplementary Table 2 from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

Markus Frank

2023

View PDFchevron_right

Cell-based vaccination against melanoma – background, preliminary results, and perspective

Dirk Schadendorf

Journal of Molecular Medicine, 1999

View PDFchevron_right

Supplementary Table 3 from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

Markus Frank

2023

View PDFchevron_right

UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma

Lea Eisenbach

Cell, 2019

View PDFchevron_right

Immune system: a double-edged sword in cancer

Lakshmi Narendra

Inflammation Research, 2013

View PDFchevron_right

Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study

Janice Austin

Annals of Surgical Oncology, 2020

View PDFchevron_right

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers

Olga Vornicova

International Journal of Molecular Sciences, 2023

View PDFchevron_right

Aspects of cancer immunotherapy

Bruce Loveland

Immunology and Cell Biology, 2003

View PDFchevron_right

A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death

Ana Ana

Current Biology, 2001

View PDFchevron_right

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Luke barker

Cancer Research, 2020

View PDFchevron_right

Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells

Cristina SANTANTONIO

Cancer Immunology, Immunotherapy, 2002

View PDFchevron_right

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

asma gati

Cancer Immunology, Immunotherapy, 2006

View PDFchevron_right

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Genny Del Zotto

Journal of Translational Medicine, 2018

View PDFchevron_right

Local irradiation of murine melanoma affects the development of tumour-specific immunity

William Mcbride

Immunology, 2009

View PDFchevron_right

In Vivo Melanoma Cell Morphology Reflects Molecular Signature and Tumor Aggressiveness

Roberta Lotti

Journal of Investigative Dermatology, 2022

View PDFchevron_right

T Cell Immunity Induced by Live, Necrotic, and Apoptotic Tumor Cells

Wolf Bartholomae

The Journal of Immunology, 2004

View PDFchevron_right

An evolutionary perspective on anti-tumor immunity

David Klinke

View PDFchevron_right

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma

Abdallah Badou

Frontiers in Immunology, 2023

View PDFchevron_right

Immune dysregulation in cancer patients developing immune-related adverse events

Shaheen Banu Khan

British Journal of Cancer, 2018

View PDFchevron_right

Immunotherapy: breakthrough in Cancer Treatment

Mrs. Reshmi Gopalakrishnan

2023

View PDFchevron_right

Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype

Richard Wu

Clinical Cancer Research, 2012

View PDFchevron_right

Cancer Vaccines and Tumor Immunity

Veronica Preda

2007

View PDFchevron_right

Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103−and XCR1+CD103+dendritic cells

Rachael Zemek

OncoImmunology, 2015

View PDFchevron_right

Immunotherapy: A Novel Approach to Fight Cancer

Fateh Singh

International Journal of Current Microbiology and Applied Sciences, 2020

View PDFchevron_right

Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma

Mary Brady

Annals of Surgical Oncology, 2013

View PDFchevron_right

Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets

Nadia Al-Banna

Journal of Clinical Investigation, 2019

View PDFchevron_right

The immunoregulatory mechanisms of carcinoma for its survival and development

Caigan Du

Journal of Experimental & Clinical Cancer Research, 2011

View PDFchevron_right

Identification of new genes associated with melanoma

Thomas Stempfl

Experimental Dermatology, 2011

View PDFchevron_right

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Vincenzo Montesarchio

Journal of Translational Medicine

View PDFchevron_right

Paucity of Tumor-infiltrating Lymphocytes Is an Unfavorable Prognosticator and Predicts Lymph Node Metastases in Cutaneous Melanoma Patients

Rafał Matkowski

Anticancer Research, 2015

View PDFchevron_right

Immunotherapy Outcomes in Advanced Melanoma in Relation to Age

Issam Makhoul

The Permanente Journal, 2020

View PDFchevron_right

Genes and signaling pathways affecting the pathogenesis of melanoma

Bridget Varughese

Postdoc Journal, 2013

View PDFchevron_right